Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation | Haematologica
PDF) Quantitative Serum Free Light Chain Assay - Analytical Issues
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Freelite® & Hevylite®
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Serum free light chains in clinical laboratory diagnostics - ScienceDirect
Freelite® & Hevylite®
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Freelite® & Hevylite®
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Cancers | Free Full-Text | Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma | Leukemia
Binding Site | What is Freelite
